ZA916026B - Process for the enzymatic preparation of basic fibroblast growth factor - Google Patents

Process for the enzymatic preparation of basic fibroblast growth factor

Info

Publication number
ZA916026B
ZA916026B ZA916026A ZA916026A ZA916026B ZA 916026 B ZA916026 B ZA 916026B ZA 916026 A ZA916026 A ZA 916026A ZA 916026 A ZA916026 A ZA 916026A ZA 916026 B ZA916026 B ZA 916026B
Authority
ZA
South Africa
Prior art keywords
bfgf
growth factor
thr
fibroblast growth
adduct
Prior art date
Application number
ZA916026A
Other languages
English (en)
Inventor
Pierre Monsan
Monsan Pierre
Francois Paul
Paul Francois
Didier Betbeder
Betbeder Didier
Paolo Sarmientos
Sarmientos Paolo
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ZA916026B publication Critical patent/ZA916026B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA916026A 1990-08-02 1991-07-31 Process for the enzymatic preparation of basic fibroblast growth factor ZA916026B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909017008A GB9017008D0 (en) 1990-08-02 1990-08-02 Process for the enzymatic preparation of basic fibroblast growth factor

Publications (1)

Publication Number Publication Date
ZA916026B true ZA916026B (en) 1992-04-29

Family

ID=10680087

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA916026A ZA916026B (en) 1990-08-02 1991-07-31 Process for the enzymatic preparation of basic fibroblast growth factor

Country Status (27)

Country Link
US (1) US5348863A (cs)
EP (1) EP0495049B1 (cs)
JP (1) JPH05501655A (cs)
KR (1) KR100191697B1 (cs)
CN (1) CN1033810C (cs)
AT (1) ATE152122T1 (cs)
AU (1) AU643822B2 (cs)
CA (1) CA2066174A1 (cs)
CZ (1) CZ286237B6 (cs)
DE (1) DE69125810T2 (cs)
DK (1) DK0495049T3 (cs)
ES (1) ES2103822T3 (cs)
FI (1) FI921428A0 (cs)
GB (1) GB9017008D0 (cs)
GR (1) GR3024111T3 (cs)
HU (1) HU212671B (cs)
IE (1) IE912729A1 (cs)
IL (1) IL98988A (cs)
MY (1) MY107334A (cs)
NO (1) NO301480B1 (cs)
NZ (1) NZ239204A (cs)
PH (1) PH31240A (cs)
PT (1) PT98544B (cs)
RU (1) RU2093519C1 (cs)
WO (1) WO1992002539A1 (cs)
YU (1) YU48309B (cs)
ZA (1) ZA916026B (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU659723B2 (en) * 1992-02-14 1995-05-25 Kaken Pharmaceutical Co., Ltd. Remedy for airway diseases
CZ289439B6 (cs) * 1994-04-21 2002-01-16 Novo Nordisk A/S Farmaceutický prostředek pro prevenci nebo léčbu sepse
US5939390A (en) * 1995-03-09 1999-08-17 Novo Nordisk A/S Pharmaceutical composition
US6274712B1 (en) 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
RU2187118C2 (ru) * 2000-07-13 2002-08-10 Российский научно-исследовательский нейрохирургический институт им. проф. А.Л. Поленова Способ диагностики возможности рецидивов церебральных рацемозных артериовенозных мальформаций
IL141647A0 (en) 2001-02-26 2002-03-10 Yeda Res & Dev Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
BRPI0406647A (pt) 2003-01-06 2005-12-06 Angiochem Inc Método para transportar um composto através da barreira sanguìnea do cérebro
UA83816C2 (ru) 2003-01-14 2008-08-26 Тева Фармасьютикал Индастриз, Лтд ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, КОТОРАЯ СОДЕРЖИТ ПЕПТИД И ЗАМЕЩЕННЫЙ β-ЦИКЛОДЕКСТРИН, ДЛЯ ЛЕЧЕНИЯ СИСТЕМНОЙ КРАСНОЙ ВОЛЧАНКИ
JP5064212B2 (ja) 2004-05-05 2012-10-31 ヴァロリザーシヨン−ルシェルシュ，ソシエテ・アン・コマンディット インターロイキン−１受容体アンタゴニスト、組成物、及び治療方法
US8618054B2 (en) 2004-05-05 2013-12-31 Valorisation-Rechereche Société en Commandite Interleukin-1 receptor antagonists, compositions, and methods of treatment
WO2007004060A2 (en) 2005-05-05 2007-01-11 Valorisation Hsj, Societe En Commandite Cytokine receptor modulators and uses thereof
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
WO2008144919A1 (en) 2007-05-29 2008-12-04 Angiochem, Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
CN102026667B (zh) 2008-04-18 2014-06-25 安吉奥开米公司 紫杉醇、紫杉醇类似物或紫杉醇结合物的药物组合物及相关制备方法和用途
MX2011004019A (es) 2008-10-15 2011-06-24 Angiochem Inc Conjugados de etoposido y doxorubicina para entrega de farmacos.
JP2012505637A (ja) 2008-10-15 2012-03-08 アンジオケム，インコーポレーテッド Ｇｌｐ−１アゴニストのコンジュゲート及びその使用
MX2011005963A (es) 2008-12-05 2011-09-01 Angiochem Inc Conjugados de neurotensina o analogos de neurotensina y sus usos.
EP2373789A4 (en) 2008-12-17 2012-08-29 Angiochem Inc MEMBRANTYP-1 MATRIX METALLOPROTEINASE INHIBITORS AND THEIR USE
US9173891B2 (en) 2009-04-20 2015-11-03 Angiochem, Inc. Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
JP5932642B2 (ja) 2009-07-02 2016-06-08 アンジオケム インコーポレーテッド 多量体ペプチドコンジュゲートおよびその使用
WO2012000118A1 (en) 2010-07-02 2012-01-05 Angiochem Inc. Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
BR112015028710A2 (pt) * 2013-05-16 2017-09-19 Agency Science Tech & Res Sulfato de heparan hs8 isolado ou substancialmente purificado, composição farmacêutica ou medicamento, implante biocompatível ou prótese, método de formação de um implante ou prótese biocompatível, método de cultivo de células-tronco, método de enriquecimento para unidades formadoras de colônias, meio de cultura, kit de peças, produtos e método para aumentar a estabilidade de um fator de crescimento
US10493012B2 (en) 2014-11-19 2019-12-03 Agency For Science, Technology And Research Cosmetic use of heparan sulphate
SG11201704085QA (en) 2014-11-19 2017-06-29 Agency Science Tech & Res Heparan sulphates for use in repair and/or regeneration of skin
JP6823055B2 (ja) 2015-06-15 2021-01-27 アンジオケム インコーポレーテッド 軟髄膜癌腫症の治療方法
CN105294851B (zh) * 2015-12-07 2019-02-12 中国科学院长春应用化学研究所 与几丁质特异结合的碱性成纤维细胞生长因子及其编码基因、制备方法与应用
CN114965839A (zh) * 2022-05-11 2022-08-30 朗肽生物制药股份有限公司 人碱性成纤维细胞生长因子的肽图分析方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956455A (en) * 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
US4785079A (en) * 1984-11-09 1988-11-15 The Salk Institute For Biological Studies Isolation of fibroblast growth factor
US5026839A (en) * 1985-12-17 1991-06-25 Synergen, Inc DNA encoding a basic fibroblast growth factor
DE3811921A1 (de) * 1988-04-09 1989-10-19 Hoechst Ag Verfahren zur herstellung von proteinen, die n-terminal mit prolin beginnen
US5136025A (en) * 1990-04-04 1992-08-04 California Biotechnology Inc. Method to purify basic fibroblast growth factor

Also Published As

Publication number Publication date
YU48309B (sh) 1998-05-15
US5348863A (en) 1994-09-20
CS236291A3 (en) 1992-02-19
PT98544B (pt) 1999-01-29
NO921236L (no) 1992-03-30
IE912729A1 (en) 1992-02-12
JPH05501655A (ja) 1993-04-02
NZ239204A (en) 1993-11-25
DK0495049T3 (da) 1997-08-25
DE69125810D1 (de) 1997-05-28
FI921428A7 (fi) 1992-04-01
EP0495049B1 (en) 1997-04-23
PT98544A (pt) 1992-06-30
CN1058597A (zh) 1992-02-12
NO301480B1 (no) 1997-11-03
PH31240A (en) 1998-06-18
AU643822B2 (en) 1993-11-25
CA2066174A1 (en) 1992-02-03
KR100191697B1 (ko) 1999-06-15
GR3024111T3 (en) 1997-10-31
KR920702371A (ko) 1992-09-03
HUT64564A (en) 1994-01-28
WO1992002539A1 (en) 1992-02-20
EP0495049A1 (en) 1992-07-22
FI921428L (fi) 1992-04-01
CZ286237B6 (cs) 2000-02-16
IL98988A (en) 1997-02-18
HU9201101D0 (en) 1992-08-28
FI921428A0 (fi) 1992-04-01
YU131991A (sh) 1994-05-10
ES2103822T3 (es) 1997-10-01
IL98988A0 (en) 1992-07-15
RU2093519C1 (ru) 1997-10-20
MY107334A (en) 1995-11-30
AU8304491A (en) 1992-03-02
NO921236D0 (no) 1992-03-30
GB9017008D0 (en) 1990-09-19
DE69125810T2 (de) 1997-08-07
ATE152122T1 (de) 1997-05-15
CN1033810C (zh) 1997-01-15
HU212671B (en) 1996-09-30

Similar Documents

Publication Publication Date Title
GB9017008D0 (en) Process for the enzymatic preparation of basic fibroblast growth factor
DE69020794D1 (de) Enzymatische Entfernung einer aminoterminalen Proteinsequenz.
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
DE59108934D1 (de) Verfahren zur Herstellung von L-Phosphinothricin durch eine gekoppelte enzymatische Reaktion
AU7224887A (en) Process for the printing of shaped articles derived from aramid fibers
DE69433755D1 (de) Verfahren zur Herstellung von Imidazolin abgeleiteten Amphoacetat-Tensiden von höherer Reinheit
CA2232240A1 (en) Peptide for inhibiting growth of smooth muscle cells
CA2114862A1 (en) Process for the synthesis of semi-synthetic glycosaminoglycans with heparin or heparan structure modified in position 2 of the .alpha.-l-iduronic-2-0-sulfate acid
ATE128445T1 (de) Supraleitende bi-sr-ca-cu oxid-zusammensetzungen und verfahren zur herstellung.
FR2708603B1 (fr) Procédé de préparation d'hydroperoxyde de cumène.
EP0414171A3 (en) Process for the enzymatic synthesis of components of galactosylated glycoproteins
HUT58832A (en) Galvanising bath for process for producing decorative chromine coating
DE59805677D1 (de) Froststabilisierung von wässrigen überzugsmitteln durch frostschutzproteine
Trickett BS 5750: Implications?
IL100093A (en) Thrombin-binding substance and process for preparing the same
WO1995020602A3 (en) ANALOGS OF THYMOSIN α¿1?
EP0347734A3 (en) Substrates for determination of enzyme activity and intermediates for synthesis of the substrates as well as process for producing the intermediates